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Abstract
The objective of this study was to determine what blood cell types express the B
lymphocyte-induced maturation protein-1 (BLIMP-1) gene. Such findings would be
instrumental in research regarding the aryl hydrocarbon receptor (AhR) which is
important in immune responses. The experimental model was a transgenic mouse that
expresses the enhanced yellow fluorescent protein (eYFP) under the control of the
BLIMP-1 promoter. Testing was carried out in two parts; (1) testing mice for eYFP
presence and (2) testing mice for phenotypic cell markers. Cell samples were tested via
flow cytometry. During phase one of testing it was found that positive mice showed an
average of 0.972% eYFP positive cells, and negative mice showed an average of 0.138%
eYFP positive cells. In the second phase it was found that the eYFP+ cells express
several different markers, including CD3, CD4, CD8, and, CD11b. Additional testing
needs to be completed to further understand what these cells express, but this preliminary
data is promising for the future of the AhR and cell trafficking.
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Introduction
The aryl hydrocarbon receptor (AhR) is a promising component of the human
body that may improve treatments for many autoimmune diseases, including graft vs.
host and Crohn’s. The receptor has had countless hours of research poured into it, and
there is still more being conducted in an attempt to understand the receptor’s workings
and impacts on the body, particularly within the immune system and inflammatory
response. It is known that the AhR is highly receptive to 2, 3, 7, 8-tetrachlorodibenzo p
dioxin (TCDD), but the effects TCDD has on the AhR, and the implications this
activation has on the human body are still not completely understood.
The aryl hydrocarbon receptor (AhR) was discovered 40 years ago and is
promising in a multitude of medical arenas (Esser et al., 2018). After its original
discovery, there was much research conducted to determine the workings of the AhR, but
despite this, it is still not entirely understood what role this receptor plays within the
body, especially regarding immune response (Sulentic & Kaminski, 2010).
The AhR is a ligand-activated protein receptor that is part of the Per-Arnt-Sim
(PAS) protein family which regulates metabolism, circadian rhythms, hormone
production, development, and immune function (McIntosh, Hogenesch, Bradfield, 2010).
A unique and medically relevant component to the AhR is that there are many different
ligands that will activate it. These ligands can come from plants, bacteria, or chemicals
within the cell (Esser et al., 2018). One of the ligands the AhR has the highest affinity
for is 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD). TCDD has a longer half-life with
the AhR, and as a result is the most widely used in research as a model (Ramos, 2019).
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Enhanced yellow fluorescent protein (eYFP) is a commonly used transgenic
marker in research. It is a valuable tool for tracking cells throughout the body and in
research and has been used in many research laboratories, such as those tracking immune
pathways and the trafficking of immune cells (Xiaoxi, et al., 2011; Bullock, et al., 2008).
eYFP is expressed on the Blimp-1 (B lymphocyte induced maturation protein) promoter,
which is used to induce the maturation and differentiation of B lymphocytes (Turner, et
al., 1994). Beyond B cells, Blimp-1 expression is also seen in T cells, especially in CD4+
and CD8+ ones; however, this expression has been found to be restricted predominantly
to activated T cells (Fu, et al., 2017).
Significance
In order to maintain optimal health, the body must properly defend against
pathogens. One of the greatest exposure to these occurs within the GI tract. When
pathogens enter the gut, antibodies bind to them to neutralize their attack and prevent
advancement into other portions of the body (Macpherson, Geurking, McCoy, 2012). B
cells and other immune cells gather in the lamina propria (LP) in preparation to intercept
pathogens (Brandtzaeg et al., 1999). Many of these B cells migrate from other parts of the
body, and some migrate selectively to the LP (Habetzion, et al., 2016). During the
immune response, B cells secrete antibodies to defend against pathogens. Most of this
antibody creation occurs within the LP (Ramos, 2019). Migration into the LP is crucial
for proper immune defense so these antibody-secreting B cells are in the correct place to
intercept pathogens.
The AhR plays a critical role in the migration of some immune cells. Previous
research by others has demonstrated that the AhR regulates the migration of T cells into
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the gut as well as T regulatory cell (Treg) differentiation (Qunintana et al., 2010). It is
possible to activate the AhR with a wide array of foods and drugs, and some entire
experiments have been conducted using food exclusively (Ramos, 2019).
Activation of the AhR in one study showed an increased average β7-integrin
expression on CD3+ cells (Ramos). Previous research has also shown that when T-cells
are primed and activated by the gut-associated lymphoid tissue, integrin α4β7 and CCR9
are upregulated, which directs them to the lamina propria (Habetzion, et al., 2016). In
mice without β7, an immune igA response to cholera toxin could not be properly
mounted (Schippers, et al., 2012). These models suggest that the AhR can change the
expression of β7-integrin from T cells, which in turn impacts the migration of T cells to
the LP.
If the expression of eYFP on specific T cells can be fully understood, then
specific cells and coreceptors can be manipulated to better understand the trafficking of
immune cells. This would be especially important with regards to tracking cells as they
respond to the AhR, as well as understanding what types of T and B cells are being
signaled by the AhR. If immune responses such as these can be better understood then
those methods could be utilized therapeutically in autoimmune diseases such as Crohn’s
and graft vs. host. Although mice models aren’t completely representative of effects in
humans, these findings are promising for developments in autoimmune therapies.
Methods
This study was carried out in strict accordance with the recommendations in the
Guide for the Care and Use of Laboratory Animals of the National Institutes of Health
(National Research Council, 1996). The animal protocol was approved by the
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Institutional Animal Care and Use Committee at UNC. All efforts were made to
minimize suffering.
eYFP Transgenic Presence
Testing for eYFP was completed by cheek bleeding mice via lancelet, lysing
blood in AKC buffer, then washing cells in medium before resuspending in cell staining
buffer. Flow cytometry via the Attune NxT V6 flow cytometer was utilized to assess
eYFP presence. Mice expressing >0.52% eYFP+ were deemed to be positive for the
gene, as per previous work in the laboratory (Hufford, et al.).
Gating for eYFP presence was done in three stages. The first was to run all cells
and isolate the lymphocyte population, eliminating erythrocytes and any other cells. The
second gate was created using FSC-A vs. FSC-H and eliminated all doublets and
remaining cell fragments, so only single lymphocytes were read. The final gate took this
single-cell population and used eYFP-H vs. SSC-A to measure the eYFP presence in the
cells.
eYFP Phenotyping
T cell markers were assessed by euthanizing the mice via carbon dioxide, then
extracting blood from the heart. This blood was then lysed via AKC lysis buffer, washed
in cell medium, and then cell counts were performed using a hemocytometer. Once the
cell counts were completed, 100,000 cells were transferred into tubes before antibodies
were added. Following antibody addition and incubation, flow cytometry was run to
assess for T cells markers and confirm eYFP presence.
Gating for cell phenotyping was conducted in five stages, with the first three
being similar to that for eYFP transgenic presence testing. Following eYFP assessment,
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eYFP positive cells were gated for in an SSC-A vs. CD3 plot. CD3 positive cells were
gated and then placed in a CD4 vs. CD8 quadrant.
Results
eYFP Transgenic Presence
A total of 23 mice were assessed for eYFP transgenic presence via live blood
collection as detailed above. Samples were then analyzed via flow cytometry (Table 1).
Of the 23 total mice, there were 9 confirmed positive, 13 confirmed negative, and one
inconclusive. Negative mice were either euthanized or used as negative controls in other
experiments. Positive male mice were either used as stud mice for breeder cages if
needed or as positive controls. Positive female mice were used as positive controls in
later experiments. Positive mice showed an average of 0.972% eYFP positive cells, and
negative mice showed an average of 0.138% eYFP positive cells.

Mouse

eYFP %

eYFP Status

Mouse

eYFP %

eYFP Status

19.8.2 LR

0.551

Positive

24.5.2L

0.389

Negative

19.8.2L

0.546

Positive

24.5.2R

0.187

Negative

19.8.2R

0.537

Positive

25.1.1-

1.103

Positive

19.8.2-

0.019

Negative

25.1.1L

0.077

Negative

24.3.2R

0.178

Negative

26.2.1-

0.346

Negative

24.3.2-

0.673

Positive

26.1.2-

0.042

Negative

24.3.2L

0

Negative

26.1.2L

0.068

Negative

24.3.1R

0.371

Negative

26.4.2L

1.302

Positive

24.3.1L

0

Negative

27.1.1-

1.160

Positive
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24.3.1-

N/A

Inconclusive

27.1.1L

1.322

Positive

24.5.1-

1.556

Positive

27.1.1R

0.048

Negative

24.5.1L

0.076

Negative

Table 1. Mouse identifier, eYFP reading from flow cytometry, and conclusion

eYFP Phenotyping
Mice with confirmed eYFP positive or negative were screened for phenotypes.
These included CD3, CD4, CD8, CD11b, and GR1. Additionally, flow cytometry gating
was used to assess for mice that were double or triple positive. Isotype controls and
negative stains were run for all mice and antibodies. Of the four cell samples stained for
CD3, three were confirmed eYFP positive, and one was a confirmed negative. The
samples showed eYFP positive and negative as previously determined when assessed
following necropsy. All four samples were positive for CD3 and eYFP but not for CD3,
CD8, and eYFP.
Three mice were stained for CD3, CD4, and CD8. Two of these were positive for
eYFP. One sample showed 5.106% of cells as CD3+CD8+eYFP positive. This occurred
in the mouse that was 10 months old. Of the other two samples, one was 0.697% positive
for the CD3+CD8+eYFP staining, and the other was inconclusive.
Mice stained for CD4, CD8, and a CD11b/GR1 combo were found to be positive
for the antibodies they were stained for. The cells stained for CD4 were found to be
positive for CD4 and CD11b. Similarly, cells stained for CD11b/GR1 were also found to
be positive for CD4.
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Mouse

Antibody

eYFP %

eYFP+CD3
%

CD3, CD8,
eYFP

Conclusion

27.1.1L

CD3

3.385

7.842

0

T-cell w/ eYFP

27.1.1R

CD3

0.035

5.023

0

T-cell

27.1.1-

CD3

2.069

8.721

0

T-cell w/ eYFP

24

CD3

2.868

3.621

0

T-cell w/ eYFP

27.1.1-

CD3/CD4/CD8

1.803

12.064

0.697

Cytotoxic T-cell w/
eYFP

24

CD3/CD4/CD8

3.796

3.982

5.106

Cytotoxic T-cell w/
eYFP

27.1.1R

CD3/CD4/CD8

0.133

3.545

N/A

T-cell

Table 2. Mouse identifier, antibody tested for, percent eYFP positive cells from flow cytometry, percent
eYFP and CD3 positive cells, percent CD3+CD8+eYFP cells, and conclusion

Discussion
Although the sample size is small, this study also suggests that eYFP positive
cells do not generally express double or triple positive for CD3/CD4/CD8. As expected,
this does suggest that eYFP cells are positive for the CD3 marker, which is the general
marker for T-cells. The mouse that was CD3+CD8+eYFP suggests that eYFP cells are
cytotoxic T-cells. The CD4 expression suggests that those cells are T-helpers, and those
that express CD4 and CD11b are T-helpers and monocytes/macrophages.
Conclusion
This study continues to support that eYFP transgenic testing via cheek bleeding is
a viable and accurate way to test for eYFP presence in mice. Preliminarily, this data
suggests that eYFP positive cells in transgenic mice are T-cells, T-helper cells,
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monocytes, and sometimes are cytotoxic T-cells. More testing needs to be run to confirm
these findings.
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